AXDX
Accelerate Diagnostics Inc
NASDAQ: AXDX · HEALTHCARE · MEDICAL DEVICES
$0.03
+0.00% today
Updated 2026-04-29
Market cap
$859920.00
P/E ratio
—
P/S ratio
0.07x
EPS (TTM)
$-2.15
Dividend yield
—
52W range
$0 – $1
Volume
—
Accelerate Diagnostics Inc (AXDX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-281.70%
ROE
0.00%
ROA
-73.70%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2005 | $502110.00 | $-2.09M | 69.03% | -449.89% | -416.40% |
| 2006 | $212701.00 | $-3.03M | 80.44% | -1,506.59% | -1,424.83% |
| 2007 | $183130.00 | $-1.92M | 69.07% | -1,154.63% | -1,050.75% |
| 2008 | $475520.00 | $-1.68M | 97.97% | -363.31% | -353.37% |
| 2009 | $1.27M | $-714197.00 | 100.00% | -53.48% | -56.24% |
| 2010 | $2.25M | $641747.00 | 100.00% | 27.24% | 28.58% |
| 2011 | $1.12M | $-378761.00 | 100.00% | -36.52% | -33.78% |
| 2012 | $236000.00 | $-5.31M | 100.00% | -2,267.80% | -2,250.42% |
| 2013 | $48285.00 | $-15.28M | 100.00% | -31,709.35% | -31,649.21% |
| 2014 | $122000.00 | $-30.93M | 100.00% | -25,833.61% | -25,354.92% |
| 2015 | $147000.00 | $-45.50M | 100.00% | -30,985.71% | -30,951.02% |
| 2016 | $246000.00 | $-66.37M | 100.00% | -27,032.93% | -26,981.30% |
| 2017 | $4.18M | $-62.88M | 76.01% | -1,536.56% | -1,505.43% |
| 2018 | $5.67M | $-88.33M | 43.79% | -1,417.44% | -1,557.78% |
| 2019 | $9.30M | $-84.31M | 47.33% | -783.38% | -906.80% |
| 2020 | $11.16M | $-78.21M | 39.94% | -570.53% | -700.47% |
| 2021 | $11.78M | $-77.70M | -3.23% | -607.37% | -659.50% |
| 2022 | $12.75M | $-62.49M | 25.90% | -492.51% | -490.06% |
| 2023 | $12.06M | $-61.62M | 21.15% | -448.03% | -510.97% |
| 2024 | $11.70M | $-50.05M | 23.12% | -301.85% | -427.81% |